CRNDE showed low expression in WHO grade II samples, while the expression of LINC00665 and NEAT1 remained stable across glioma grades in the CGGA cohorts (Figure 3E, Supplementary Figures S1D,E). This evidence concerns the gene NEAT1 and central nervous system cancer.